What does DOCTEUR EURYDICE NOBLESSE do?

DOCTEUR EURYDICE NOBLESSE is a specialist medical practice in Aubange. Private Limited, started on 15 November 2007.

What is the address of DOCTEUR EURYDICE NOBLESSE?

The registered office of DOCTEUR EURYDICE NOBLESSE is located at Rue Octave Gigi - AUBANGE 1, 6790 Aubange.

Is DOCTEUR EURYDICE NOBLESSE still active?

Yes. According to the CBE (31 October 2026) DOCTEUR EURYDICE NOBLESSE is active, legal situation “Normale toestand”, started on 15 November 2007.

Is DOCTEUR EURYDICE NOBLESSE registered on Peppol?

Yes, DOCTEUR EURYDICE NOBLESSE is registered on the Peppol network with ID 0208:0893483826.

What is the enterprise number of DOCTEUR EURYDICE NOBLESSE?

The enterprise number of DOCTEUR EURYDICE NOBLESSE is BE0893483826.

When was DOCTEUR EURYDICE NOBLESSE founded?

DOCTEUR EURYDICE NOBLESSE was founded on 15 November 2007.

Who are the directors of DOCTEUR EURYDICE NOBLESSE?

According to the 2025 annual accounts, the directors of DOCTEUR EURYDICE NOBLESSE are: Eurydice Noblesse.

Is DOCTEUR EURYDICE NOBLESSE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 November 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR EURYDICE NOBLESSE make in 2025?

DOCTEUR EURYDICE NOBLESSE posted a profit after taxes of € 51,250 in financial year 2025.

What is the revenue of DOCTEUR EURYDICE NOBLESSE?

As a small company, DOCTEUR EURYDICE NOBLESSE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 52,789.

DOCTEUR EURYDICE NOBLESSE (Private Limited) - Aubange

Dossier DOCTEUR EURYDICE NOBLESSE, printed on 31 October 2026 from databakkes.be/en/0893483826/docteur-eurydice-noblesse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 3 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2022.

Financials

Financial year 2025

DOCTEUR EURYDICE NOBLESSE from Aubange, company number BE0893483826, closed financial year 2025 with a result of € 51,250 after tax. For that financial year DOCTEUR EURYDICE NOBLESSE recorded a gross margin of € 52,789 and equity of € -73,653. Compared with financial year 2024, the result moved from € -19,559 to € 51,250. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Caution

€ -73,653

▲ € 51,250 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 51,250

▲ still € 19,559 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 118,698

▲ 85% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -92,253.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,424

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 174

▼ 75% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -9,013 Gross margin 2022: € -9,013 First fiscal year in the series	€ -25,937 Gross margin 2023: € -25,937 ▼ € 16,925 vs 2022 (€ -9,013) Unfavourable step	€ -18,924 Gross margin 2024: € -18,924 ▲ € 7,013 vs 2023 (€ -25,937) Favourable step	€ 52,789 Gross margin 2025: € 52,789 ▲ € 71,713 vs 2024 (€ -18,924) Favourable step	▲ € 71,713
Profit after taxes	€ -13,068 Profit after taxes 2022: € -13,068 First fiscal year in the series	€ -28,362 Profit after taxes 2023: € -28,362 ▼ € 15,295 vs 2022 (€ -13,068) Unfavourable step	€ -19,559 Profit after taxes 2024: € -19,559 ▲ € 8,803 vs 2023 (€ -28,362) Favourable step	€ 51,250 Profit after taxes 2025: € 51,250 ▲ € 70,808 vs 2024 (€ -19,559) Favourable step	▲ € 70,808
Equity	€ 73,093 Equity 2022: € 73,093 First fiscal year in the series	€ -105,344 Equity 2023: € -105,344 ▼ € 178,437 vs 2022 (€ 73,093) Unfavourable step	€ -124,903 Equity 2024: € -124,903 ▼ € 19,559 vs 2023 (€ -105,344) Unfavourable step	€ -73,653 Equity 2025: € -73,653 ▲ € 51,250 vs 2024 (€ -124,903) Favourable step	▲ € 51,250
Total debts	€ 40,471 Total debts 2022: € 40,471 First fiscal year in the series	€ 186,872 Total debts 2023: € 186,872 ▲ € 146,401 vs 2022 (€ 40,471) Unfavourable step	€ 195,544 Total debts 2024: € 195,544 ▲ 5% vs 2023 (€ 186,872) Unfavourable step	€ 211,851 Total debts 2025: € 211,851 ▲ 8% vs 2024 (€ 195,544) Unfavourable step	▲ 8%
Cash	€ 110,375 Cash 2022: € 110,375 First fiscal year in the series	€ 71,143 Cash 2023: € 71,143 ▼ 36% vs 2022 (€ 110,375) Unfavourable step	€ 64,302 Cash 2024: € 64,302 ▼ 10% vs 2023 (€ 71,143) Unfavourable step	€ 118,698 Cash 2025: € 118,698 ▲ 85% vs 2024 (€ 64,302) Favourable step	▲ 85%
Retained profit	€ -95,582 Retained profit 2022: € -95,582 First fiscal year in the series	€ -123,944 Retained profit 2023: € -123,944 ▼ € 28,362 vs 2022 (€ -95,582) Unfavourable step	€ -143,503 Retained profit 2024: € -143,503 ▼ € 19,559 vs 2023 (€ -123,944) Unfavourable step	€ -92,253 Retained profit 2025: € -92,253 ▲ € 51,250 vs 2024 (€ -143,503) Favourable step	▲ € 51,250
Balance sheet total	€ 113,564 Balance sheet total 2022: € 113,564 First fiscal year in the series	€ 81,528 Balance sheet total 2023: € 81,528 ▼ 28% vs 2022 (€ 113,564) Unchanged	€ 70,642 Balance sheet total 2024: € 70,642 ▼ 13% vs 2023 (€ 81,528) Unchanged	€ 138,198 Balance sheet total 2025: € 138,198 ▲ 96% vs 2024 (€ 70,642) Unchanged	▲ 96%

Key figures of DOCTEUR EURYDICE NOBLESSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR EURYDICE NOBLESSE?

What happened at DOCTEUR EURYDICE NOBLESSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 51,250. Source: NBB ↗
2023 Eurydice Noblesse became a director. NBB
Nov 15, 2007 Start of the company according to the CBE. KBO

In short

From € 13,068 loss in 2022 to € 51,250 profit in 2025.

Paid € 612 in corporate taxes since 2022.

Best year ever: 2025, with € 51,250 profit.

Original PDFs at the National Bank ↗

Management

Eurydice Noblesse

DOCTEUR EURYDICE NOBLESSE

Behind DOCTEUR EURYDICE NOBLESSE is Eurydice Noblesse.

Directors

According to the 2025 annual accounts

Eurydice Noblesse

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Octave Gigi - AUBANGE 1

6790 Aubange

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0893.483.826
VAT number: BE 0893.483.826
Registered office: Rue Octave Gigi - AUBANGE 1, 6790 Aubange
Names & denominations: DOCTEUR EURYDICE NOBLESSE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 November 2007
Peppol: Active · Active since 1 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗